GABA inverse agonist restores cognitive function in Down's syndrome

(European College of Neuropsychopharmacology) Promising new evidence in mice trials presented at the 26th ECNP Congress suggests GABA inverse agonist could reverse cognitive impairment and improve learning in people born with Down's syndrome.